Sonoma Pharmaceuticals
SNOA

Sonoma Pharmaceuticals (SNOA) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$0.37
EPS estimate
−$0.51
Revenue
$4.0M
Reported
Aug 7, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q1 2026Aug 7, 2025−$0.51−$0.37+27.57%$4.0MSEC
Q4 2025Jun 17, 2025−$0.73−$0.15+79.18%$3.8MSEC
Q3 2025Feb 5, 2025−$0.69−$0.59+13.84%$3.6MSEC
Q2 2025Nov 7, 2024−$0.80−$0.62+22.75%$3.6MSEC
Q1 2025Aug 8, 2024−$1.00−$1.26−26.49%$3.4MSEC
Q4 2024Jun 17, 2024−$3.41−$1.38+59.57%$3.4MSEC
Q3 2024Feb 8, 2024−$4.16−$1.20+71.23%$3.1MSEC
Q2 2024Nov 13, 2023−$3.78−$3.98−5.46%$2.7MSEC
Q1 2024Aug 10, 2023−$2.40−$4.54−88.99%$3.4MSEC
Q4 2023Jun 21, 2023$0.00−$4.68+0.00%$3.0MSEC
Q3 2023Feb 14, 2023$0.00−$12.40+0.00%$2.9MSEC

Quarterly revenue

Q3 2023
$2.9M
Q4 2023
$3.0M
Q1 2024
$3.4M
Q2 2024
$2.7M
Q3 2024
$3.1M
Q4 2024
$3.4M
Q1 2025
$3.4M
Q2 2025
$3.6M
Q3 2025
$3.6M
Q4 2025
$3.8M
Q1 2026
$4.0M

Frequently asked questions

  • When did Sonoma Pharmaceuticals (SNOA) last report earnings?

    Sonoma Pharmaceuticals last reported on Aug 7, 2025, covering fiscal Q1 2026.

  • Did SNOA beat earnings estimates?

    Yes. Sonoma Pharmaceuticals reported EPS of −$0.37 for Q1 2026 against a −$0.51 estimate — a 27.57% beat.

  • How much revenue did SNOA report last quarter?

    Sonoma Pharmaceuticals reported $4.0M in revenue for Q1 2026, against a consensus estimate of $4.0M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.